Search

Your search keyword '"Leis, Jose F."' showing total 15 results

Search Constraints

Start Over You searched for: Author "Leis, Jose F." Remove constraint Author: "Leis, Jose F." Journal american journal of hematology Remove constraint Journal: american journal of hematology
15 results on '"Leis, Jose F."'

Search Results

1. DTRMWXHS ‐12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open‐label, multicenter, phase 1a/1b study

2. Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis

4. The prognostic significance of del6q23 in chronic lymphocytic leukemia

5. Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B‐cell lymphocytosis beyond theCLLinternational prognostic index

6. Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.

7. Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare

8. IGHtranslocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes

9. Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B‐cell lymphocytosis beyond the CLL international prognostic index.

10. Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare.

11. Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings

12. Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study

13. A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR‐CD) for untreated low‐grade non‐Hodgkin lymphoma requiring therapy

15. Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison tode novoHodgkin lymphoma

Catalog

Books, media, physical & digital resources